US Patent Issued to HEM PHARMA on April 22 for "Method for screening personalized intestinal environment-improving material and composition therefor" (South Korean Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,282,026, issued on April 22, was assigned to HEM PHARMA INC. (Pohang-si, South Korea).

"Method for screening personalized intestinal environment-improving material and composition therefor" was invented by Soyoung Park (Suwon-si, South Korea) and Yosep Ji (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a composition for screening an intestinal environment-improving material and a screening method using the composition, and according to the composition and the method of the present disclosure, it is possible to provide an effective analysis method for screening a microbiota-improving candidate materi...